| Authors: |
Wang J; Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320, USA., Takundwa R; Amgen Ltd, 4 Uxbridge Business Park, Sanderson Rd., Uxbridge UB8 1DH, UK., Yang H; Analysis Group Inc., 111 Huntington Ave., 14th Fl., Boston, MA 02199, USA., Chai X; Analysis Group Inc., 111 Huntington Ave., 14th Fl., Boston, MA 02199, USA., Yu Y; Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320, USA., Zhang Y; Analysis Group Inc., 151 W 42nd St 23rd Fl., New York, NY, USA., Dirnberger F; Amgen GmbH, Riesstraße 24, 80992 Munich, Germany., Anderson ES; Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320, USA., Pastel M; Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320, USA., Pundole X; Amgen Inc., One Amgen Center Dr., Thousand Oaks, CA 91320, USA., Gomez-Randulfe I; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester M20 4BX, UK., Blackhall F; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester M20 4BX, UK; University of Manchester, Oxford Road, Manchester M13 9PL, UK. Electronic address: fiona.blackhall@nhs.net. |
